Cracking the Code of Precision Cancer Therapies
“If we are going to make advances in cancer, we’re going to have to think outside the box and have high-risk, high-reward collaborations. There’s no place better than UCSF for that type of science,” Dr. Adil Daud says.
Linda McCulloch was behind the wheel when she suffered a brain seizure that sent her car careening into a ditch. Two days later, she received a devastating diagnosis: stage 4 melanoma. But a groundbreaking clinical trial, led by Adil Daud, MD, provided a glimmer of hope.
What happened next showcases how your gifts open the door to remarkable new cancer therapies and cutting-edge research that, as Linda's case illustrates, has the potential to yield astounding results.*
*These results may not be typical.